Clinical Trials Browser

OTHER × Breast Neoplasms, Male × Erlotinib Hydrochloride × Clear all

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Phase 1/2 Completed

11 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00059852 2016-12-07

Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00574366 2016-05-10

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00054275 2016-02-17

Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer

Phase 2 Completed

39 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male